Tympanometric in patients with otitis media secretory subjected to corticosteroids treatment and autoinflation maneuver <b>[Abstract in English]</b>

Authors

  • Tiago Vidal Dimer
  • Mariane Heckmann Wender
  • Humberto Gonçalves Reis
  • Carlos Kazuo Taguchi

Abstract

Objective: To observe the tympanometric variations occurred to patients that got SOM which were subjected to corticosteroids treatment by nasal spray and autoinflation maneuver as well.
Method: 33 patients that got OMS were observed. All of them were verified by the tympanometry test at the diagnostic week and 15 and 30 days after the treatment.
Result: 42 (63,63%) of the 66 ears verified at the first week presented B type result, 22 (33,33%) presented C type and finally 2 (3,03%) presented A type. On the other hand, at the last evaluation, only 17 ears (25,76%) were still presenting B type, 26 (39,39%) presented C type and 23 (34,85%) presented A type.
Conclusion: The corticosteroids treatment by the nasal spray plus autoinflation maneuver can be a good option to SOM treatment.
KEY WORDS: OTITIS MEDIA WITH EFFUSION/therapy; HEARING LOSS; EUSTACHIAN TUBE; ACOUSTIC IMPEDANCE TESTS; ADRENAL CÓRTEX HORMONE/administration & dosage.

Downloads

Download data is not yet available.

Downloads

Published

2006-10-23

How to Cite

Dimer, T. V., Wender, M. H., Reis, H. G., & Taguchi, C. K. (2006). Tympanometric in patients with otitis media secretory subjected to corticosteroids treatment and autoinflation maneuver <b>[Abstract in English]</b>. Scientia Medica, 15(4). Retrieved from https://revistaseletronicas.pucrs.br/ojs/index.php/scientiamedica/article/view/1575

Issue

Vol. 15 No. 4 (2005)

Section

Original Articles

License

Copyright

The submission of originals to Scientia Medica implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Scientia Medica as the site of original publication.

Creative Commons License

Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.

Most read articles by the same author(s)